skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:049217/0327   Pages: 88
Recorded: 05/17/2019
Attorney Dkt #:PAT054234
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 5
1
Patent #:
Issue Dt:
11/22/2016
Application #:
14151796
Filing Dt:
01/09/2014
Publication #:
Pub Dt:
05/08/2014
Title:
Tetrahydro-Pyrido-Pyrimidine Derivatives
2
Patent #:
NONE
Issue Dt:
Application #:
15285614
Filing Dt:
10/05/2016
Publication #:
Pub Dt:
01/26/2017
Title:
Tetrahydro-Pyrido-Pyrimidine Derivatives
3
Patent #:
NONE
Issue Dt:
Application #:
15993051
Filing Dt:
05/30/2018
Publication #:
Pub Dt:
09/20/2018
Title:
Tetrahydro-Pyrido-Pyrimidine Derivatives
4
Patent #:
NONE
Issue Dt:
Application #:
16163106
Filing Dt:
10/17/2018
Publication #:
Pub Dt:
02/07/2019
Title:
Tetrahydro-Pyrido-Pyrimidine Derivatives
5
Patent #:
NONE
Issue Dt:
Application #:
16367525
Filing Dt:
03/28/2019
Publication #:
Pub Dt:
07/18/2019
Title:
Tetrahydro-Pyrido-Pyrimidine Derivatives as PI3Kdelta inhibitors
Assignors
1
Exec Dt:
07/04/2011
2
Exec Dt:
07/04/2011
3
Exec Dt:
06/30/2011
4
Exec Dt:
06/30/2011
5
Exec Dt:
06/30/2011
6
Exec Dt:
06/29/2011
7
Exec Dt:
06/30/2011
8
Exec Dt:
06/29/2011
9
Exec Dt:
06/30/2011
10
Exec Dt:
06/30/2011
11
Exec Dt:
06/30/2011
12
Exec Dt:
06/30/2011
13
Exec Dt:
06/30/2011
14
Exec Dt:
06/23/2011
Assignee
1
LICHTSTRASSE 35
BASEL, SWITZERLAND 4056
Correspondence name and address
MARK LAZAROW
ONE HEALTH PLAZA
EAST HANOVER, NJ 07936

Search Results as of: 05/24/2024 08:13 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT